A proof of concept study of CB-103 for treatment of graft-versus-host disease (GvHD)
Latest Information Update: 23 Jan 2024
At a glance
- Drugs CB 103 (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
Most Recent Events
- 23 Jan 2024 New trial record